BOSTON SCIENTIFIC CORP — Director's Dealing 2023

Feb 21, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2023-02-16

Reporting Person: Brown Vance R (SVP, GC and Corp. Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-16	Common Stock	M	1838.0000	$0.0000	Acquired	40440.0000	Direct
2023-02-16	Common Stock	F	568.0000	$46.4800	Disposed	39872.0000	Direct
2023-02-17	Common Stock	M	1000.0000	$0.0000	Acquired	40872.0000	Direct
2023-02-17	Common Stock	F	294.0000	$46.5400	Disposed	40578.0000	Direct
2023-02-18	Common Stock	M	741.0000	$0.0000	Acquired	41319.0000	Direct
2023-02-18	Common Stock	F	218.0000	$46.5400	Disposed	41101.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-16	Restricted Stock Units	$	M	1838.0000	Disposed	2026-02-16	Common Stock (1838.0000)	Direct
2023-02-17	Restricted Stock Units	$	M	1000.0000	Disposed	2025-02-17	Common Stock (1000.0000)	Direct
2023-02-18	Deferred Stock Units	$	M	741.0000	Disposed	2024-02-18	Common Stock (741.0000)	Direct

Footnotes

F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.

F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.

F5: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.